Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease.

S. V. Kane, B. Neis, B. D. Becker, D. Bruining, W. A. Faubion, J. Kisiel, E. V. Loftus, D. Pardi, L. Raffals, K. Schroeder, W. J. Tremaine

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1412
Number of pages1
JournalAlimentary Pharmacology & Therapeutics
Volume38
Issue number11-12
StatePublished - Dec 2013
Externally publishedYes

Fingerprint

Drug Administration Schedule
Antibodies, Monoclonal, Humanized
Immunoglobulin Fab Fragments
Immunosuppressive Agents
Crohn Disease
Retrospective Studies
Certolizumab Pegol

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kane, S. V., Neis, B., Becker, B. D., Bruining, D., Faubion, W. A., Kisiel, J., ... Tremaine, W. J. (2013). Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease. Alimentary Pharmacology & Therapeutics, 38(11-12), 1412.

Letter : Effectiveness of split-dose certolizumab pegol for Crohn's disease. / Kane, S. V.; Neis, B.; Becker, B. D.; Bruining, D.; Faubion, W. A.; Kisiel, J.; Loftus, E. V.; Pardi, D.; Raffals, L.; Schroeder, K.; Tremaine, W. J.

In: Alimentary Pharmacology & Therapeutics, Vol. 38, No. 11-12, 12.2013, p. 1412.

Research output: Contribution to journalArticle

Kane, SV, Neis, B, Becker, BD, Bruining, D, Faubion, WA, Kisiel, J, Loftus, EV, Pardi, D, Raffals, L, Schroeder, K & Tremaine, WJ 2013, 'Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease.', Alimentary Pharmacology & Therapeutics, vol. 38, no. 11-12, pp. 1412.
Kane SV, Neis B, Becker BD, Bruining D, Faubion WA, Kisiel J et al. Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease. Alimentary Pharmacology & Therapeutics. 2013 Dec;38(11-12):1412.
Kane, S. V. ; Neis, B. ; Becker, B. D. ; Bruining, D. ; Faubion, W. A. ; Kisiel, J. ; Loftus, E. V. ; Pardi, D. ; Raffals, L. ; Schroeder, K. ; Tremaine, W. J. / Letter : Effectiveness of split-dose certolizumab pegol for Crohn's disease. In: Alimentary Pharmacology & Therapeutics. 2013 ; Vol. 38, No. 11-12. pp. 1412.
@article{c7f0bec68ae04f58a28485ccf44ef2fd,
title = "Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease.",
author = "Kane, {S. V.} and B. Neis and Becker, {B. D.} and D. Bruining and Faubion, {W. A.} and J. Kisiel and Loftus, {E. V.} and D. Pardi and L. Raffals and K. Schroeder and Tremaine, {W. J.}",
year = "2013",
month = "12",
language = "English (US)",
volume = "38",
pages = "1412",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "11-12",

}

TY - JOUR

T1 - Letter

T2 - Effectiveness of split-dose certolizumab pegol for Crohn's disease.

AU - Kane, S. V.

AU - Neis, B.

AU - Becker, B. D.

AU - Bruining, D.

AU - Faubion, W. A.

AU - Kisiel, J.

AU - Loftus, E. V.

AU - Pardi, D.

AU - Raffals, L.

AU - Schroeder, K.

AU - Tremaine, W. J.

PY - 2013/12

Y1 - 2013/12

UR - http://www.scopus.com/inward/record.url?scp=84907186196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907186196&partnerID=8YFLogxK

M3 - Article

C2 - 24206378

VL - 38

SP - 1412

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 11-12

ER -